Two-in-one inhaler cuts childhood asthma attacks by nearly half, study finds

In the first randomized controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5 to 15, an international team found the combined treatment to be more effective than salbutamol, the current standard for asthma symptom relief in children, with no additional safety concerns.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup